Preferred Name |
secukinumab |
|
Synonyms |
AIN457 Cosentyx AIN 457 AIN-457 |
|
ID |
http://purl.bioontology.org/ontology/MESH/C555450 |
|
altLabel |
AIN457 Cosentyx AIN 457 AIN-457 |
|
cui |
C3179548 C3179547 C3872092 |
|
HM |
D061067 |
|
II |
D020381/Q000037 D011565/Q000188 |
|
Inverse of RB |
DLG4EML025 |
|
LT |
TRD |
|
Mapped to | ||
MDA |
20110131 |
|
MeSH Frequency |
956 |
|
MMR |
20191101 |
|
notation |
C555450 |
|
prefLabel |
secukinumab |
|
SC |
1 |
|
Scope Statement |
a fully human antibody to interleukin-17A for treatment of psoriasis, rheumatoid arthritis, and uveitis |
|
SRC |
Sci Transl Med. 2010 Oct 6;2(52):52ra72 |
|
TERMUI |
T792320 T792321 T792319 T792322 T000874155 |
|
TH |
FDA SRS (2013) NLM (2015) USAN (19XX) INN (19XX) NLM (2011) |
|
tui |
T116 T129 T121 |
Create mapping